Trifork Group AG
41/2024・Trifork Group AG announces agreement on partial divestment of a Trifork Labs portfolio company
41/2024・Trifork Group AG announces agreement on partial divestment of a Trifork Labs portfolio company
Company announcement no. 41 / 2024
Schindellegi, Switzerland – 20 December 2024
Trifork announces agreement on partial divestment of a Trifork Labs portfolio company
The shareholders of a portfolio company in Trifork Labs have today entered into an agreement to divest 30% of the existing shares to an equity fund investor. Trifork has participated pro-rata and will continue as a minority shareholder in the company.
Financial impact of the partial sale for Trifork
The undisclosed transaction valuation exceeds the book value of the company previously recorded in Trifork Labs and therefore has a material positive impact on both realized and unrealized gains recorded in Trifork Labs. The transaction will contribute with a financial gain of EURm 9.6 in Q4 2024. More information about the transaction and its impact on Trifork Group will be shared in the Annual Report 2024.
Comment from Jørn Larsen, CEO of Trifork Group
“I am happy to see that Trifork Labs continues to build on its outstanding investment track record in disruptive technology innovators early in their entrepreneurial journeys. Trifork Labs has historically contributed to funding the Group’s investments in organic growth and acquisitions. Looking at our existing portfolio, we are confident that more success stories will emerge in the future, ensuring strong value creation for Trifork Group’s shareholders over time.”
Contact
Frederik Svanholm, Group Investment Director & Head of IR
frsv@trifork.com, +41 79 357 7317
About Trifork Group
Trifork is a pioneering global technology partner that empowers enterprise and public sector customers with innovative solutions. With 1,278 professionals across 76 business units in 15 countries, Trifork delivers expertise in inspiring, building, and running advanced software solutions across diverse sectors, including public administration, healthcare, manufacturing, logistics, energy, financial services, retail, and real estate. Trifork Group AG is a publicly listed company on Nasdaq Copenhagen. Learn more at trifork.com.
About Trifork Labs
Trifork Labs leads the venture-financed R&D activities of the Trifork Group. Trifork Labs has been active in founding, co-founding, and investing in innovative B2B software companies for more than 20 years. Today, the portfolio consists of 25 companies from around the world. Previous successful exits include global successes such as Chainalysis, Tradeshift, and Humio. By centering innovation efforts around companies founded either by Trifork’s own employees or externally by customers, partners, or entrepreneurs, the Group learns about new technologies and new possibilities of software while providing portfolio companies access to Trifork’s technical support, commercial experience, global customer base, investor network, and capital. Learn more at labs.trifork.com.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd20.12.2024 22:30:00 CET | Press release
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025
Nyxoah20.12.2024 22:30:00 CET | Press release
Publication relating to transparency notifications
Renovaro Inc20.12.2024 21:40:00 CET | Press release
Renovaro Regains Compliance with NASDAQ Listing Requirement
Nokia Oyj20.12.2024 21:30:00 CET | Press release
Nokia Corporation: Repurchase of own shares on 20.12.2024
Sequana Medical NV20.12.2024 20:00:00 CET | Press release
Press Release: Sequana Medical announces results of Extraordinary General Meeting of Shareholders and update on Convertible Financing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom